STOMACH CRUNCH

Rx-to-OTC switches in the stomach care category bring additional sales, but they can sometimes be hard for food retailers to digest, given restricted shelf space. A potential new entry to watch is the heartburn treatment drug Zegerid, from Shering-Plough Corp., Kenilworth, N.J. The drug maker applied this year to the U.S. Food and Drug Administration for a new drug application for an OTC low-dose

Rx-to-OTC switches in the stomach care category bring additional sales, but they can sometimes be hard for food retailers to digest, given restricted shelf space.

Register to view the full article